Stephan A. Veltkamp

806 total citations
19 papers, 640 citations indexed

About

Stephan A. Veltkamp is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Stephan A. Veltkamp has authored 19 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Stephan A. Veltkamp's work include Cancer Treatment and Pharmacology (5 papers), Diabetes Treatment and Management (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Stephan A. Veltkamp is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Diabetes Treatment and Management (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Stephan A. Veltkamp collaborates with scholars based in Netherlands, United States and Japan. Stephan A. Veltkamp's co-authors include Jan H.M. Schellens, Jos H. Beijnen, Ronald Smulders, Takeshi Kadokura, Dick Pluim, Ele Ferrannini, Walter Krauwinkel, Hilde Rosing, Robert S. Jansen and Maria A.J. van Eijndhoven and has published in prestigious journals such as Diabetes Care, Cancer Research and Clinical Cancer Research.

In The Last Decade

Stephan A. Veltkamp

19 papers receiving 632 citations

Peers

Stephan A. Veltkamp

MB

ONCOL

EDM

SURGE

BIOMA

Zhousheng Xiao China

Gerhard Theyer Austria

Marcella Marcellini Italy

Martin Berger Germany

Dar-Shih Hsieh Taiwan

Yongdong Niu China

Melissa Thompson United States

Anitha Shenoy India

Ruohua Chen China

Thomas Köpke Germany

Zhousheng Xiao China

Stephan A. Veltkamp

435 ×1.8

MB

265 ×1.1

ONCOL

61 ×0.4

EDM

118 ×0.9

SURGE

24 ×0.3

BIOMA

Citations per year, relative to Stephan A. Veltkamp Stephan A. Veltkamp (= 1×) peers Zhousheng Xiao

Countries citing papers authored by Stephan A. Veltkamp

Since Specialization

Citations

This map shows the geographic impact of Stephan A. Veltkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan A. Veltkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan A. Veltkamp more than expected).

Fields of papers citing papers by Stephan A. Veltkamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan A. Veltkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan A. Veltkamp. The network helps show where Stephan A. Veltkamp may publish in the future.

Co-authorship network of co-authors of Stephan A. Veltkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan A. Veltkamp. A scholar is included among the top collaborators of Stephan A. Veltkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan A. Veltkamp. Stephan A. Veltkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Leijen, Suzanne, Stephan A. Veltkamp, Alwin D. R. Huitema, et al.. (2013). Phase I dose-escalation study and population pharmacokinetic analysis of fixed dose rate gemcitabine plus carboplatin as second-line therapy in patients with ovarian cancer. Gynecologic Oncology. 130(3). 511–517. 8 indexed citations

2.

Ferrannini, Ele, Stephan A. Veltkamp, Ronald Smulders, & Takeshi Kadokura. (2013). Renal Glucose Handling. Diabetes Care. 36(5). 1260–1265. 71 indexed citations

3.

Veltkamp, Stephan A., et al.. (2012). Combination Treatment With Ipragliflozin and Metformin: A Randomized, Double-Blind, Placebo-Controlled Study in Patients With Type 2 Diabetes Mellitus. Clinical Therapeutics. 34(8). 1761–1771. 21 indexed citations

4.

Ruggieri, Michael R., Masayuki Takeda, Gommert A. van Koeveringe, et al.. (2012). How does the urothelium affect bladder function in health and disease?: ICI‐RS 2011. Neurourology and Urodynamics. 31(3). 293–299. 63 indexed citations

5.

Smulders, Ronald, Stephan A. Veltkamp, Jan van Dijk, et al.. (2012). No pharmacokinetic interaction between ipragliflozin and sitagliptin, pioglitazone, or glimepiride in healthy subjects. Diabetes Obesity and Metabolism. 14(10). 937–943. 25 indexed citations

6.

Veltkamp, Stephan A., Takeshi Kadokura, Walter Krauwinkel, & Ronald Smulders. (2011). Effect of Ipragliflozin (ASP1941), a Novel Selective Sodium-Dependent Glucose Co-Transporter 2 Inhibitor, on Urinary Glucose Excretion in Healthy Subjects. Clinical Drug Investigation. 31(12). 839–851. 52 indexed citations

7.

Veltkamp, Stephan A., Takeshi Kadokura, Walter Krauwinkel, & Ronald Smulders. (2011). Effect of Ipragliflozin (ASP1941), a Novel Selective Sodium-Dependent Glucose Co-Transporter 2 Inhibitor, on Urinary Glucose Excretion in Healthy Subjects. Clinical Drug Investigation. 1–1. 2 indexed citations

8.

Veltkamp, Stephan A., Dick Pluim, Olaf van Tellingen, Jos H. Beijnen, & Jan H.M. Schellens. (2008). Extensive Metabolism and Hepatic Accumulation of Gemcitabine After Multiple Oral and Intravenous Administration in Mice. Drug Metabolism and Disposition. 36(8). 1606–1615. 25 indexed citations

9.

Veltkamp, Stephan A., Els O. Witteveen, Angela Capriati, et al.. (2008). Clinical and Pharmacologic Study of the Novel Prodrug Delimotecan (MEN 4901/T-0128) in Patients with Solid Tumors. Clinical Cancer Research. 14(22). 7535–7544. 32 indexed citations

10.

Veltkamp, Stephan A., Robert S. Jansen, Sophie Callies, et al.. (2008). Oral Administration of Gemcitabine in Patients with Refractory Tumors: A Clinical and Pharmacologic Study. Clinical Cancer Research. 14(11). 3477–3486. 57 indexed citations

11.

Veltkamp, Stephan A., Jos H. Beijnen, & Jan H.M. Schellens. (2008). Prolonged Versus Standard Gemcitabine Infusion: Translation of Molecular Pharmacology to New Treatment Strategy. The Oncologist. 13(3). 261–276. 62 indexed citations

12.

Veltkamp, Stephan A., Dick Pluim, Maria A.J. van Eijndhoven, et al.. (2008). New insights into the pharmacology and cytotoxicity of gemcitabine and 2′,2′-difluorodeoxyuridine. Molecular Cancer Therapeutics. 7(8). 2415–2425. 77 indexed citations

13.

Veltkamp, Stephan A., Robert W. Jansen, Ignacio Garcia‐Ribas, et al.. (2007). Gemcitabine metabolite, 2’,2’-difluorodeoxyuridine (dFdU), can be phosphorylated and incorporated into nucleic acids. Cancer Research. 67. 1541–1541. 1 indexed citations

14.

Veltkamp, Stephan A., Jetske M. Meerum Terwogt, Michel M. van den Heuvel, et al.. (2007). Severe pulmonary toxicity in patients with leiomyosarcoma after treatment with gemcitabine and docetaxel. Investigational New Drugs. 25(3). 279–281. 5 indexed citations

15.

Veltkamp, Stephan A., Hilde Rosing, Alwin D. R. Huitema, et al.. (2007). Novel paclitaxel formulations for oral application: a phase I pharmacokinetic study in patients with solid tumours. Cancer Chemotherapy and Pharmacology. 60(5). 635–642. 17 indexed citations

16.

Bröker, Linda E., Stephan A. Veltkamp, Elisabeth I. Heath, et al.. (2007). A Phase I Safety and Pharmacologic Study of a Twice Weekly Dosing Regimen of the Oral Taxane BMS-275183. Clinical Cancer Research. 13(13). 3906–3912. 21 indexed citations

17.

Veltkamp, Stephan A., et al.. (2006). A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application. Cancer Chemotherapy and Pharmacology. 59(1). 43–50. 13 indexed citations

18.

Veltkamp, Stephan A., Bram Thijssen, Jean‐Sébastien Garrigue, et al.. (2006). A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer. British Journal of Cancer. 95(6). 729–734. 36 indexed citations

19.

Veltkamp, Stephan A., M. J. X. Hillebrand, Hilde Rosing, et al.. (2006). Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion‐exchange liquid chromatography coupled with tandem mass spectrometry. Journal of Mass Spectrometry. 41(12). 1633–1642. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact